Walleye Capital
TMDX icon

Walleye Capital’s Transmedics TMDX Stock Holding History

Walleye Capital’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$328K Buy
3,300
+400
+14% +$52.2K ﹤0.01% 2999
2025
Q4 		$353K Sell
2,900
-11,800
-80% -$1.48M ﹤0.01% 3185
2025
Q3 		$1.65M Sell
14,700
-2,800
-16% -$328K 0.01% 1723
2025
Q2 		$2.35M Buy
17,500
+7,100
+68% +$780K 0.01% 1389
2025
Q1 		$700K Sell
10,400
-14,900
-59% -$1.02M ﹤0.01% 2279
2024
Q4 		$1.58M Buy
25,300
+22,500
+804% +$2.09M ﹤0.01% 1998
2024
Q3 		$440K Sell
2,800
-6,800
-71% -$1.05M ﹤0.01% 3413
2024
Q2 		$1.45M Buy
+9,600
New +$1.15M ﹤0.01% 2443
2023
Q4 		– Sell
-7,600
Closed -$416K – 5515
2023
Q3 		$416K Buy
7,600
+5,700
+300% +$410K ﹤0.01% 2956
2023
Q2 		$160K Sell
1,900
-2,200
-54% -$168K ﹤0.01% 3218
2023
Q1 		$310K Buy
4,100
+400
+11% +$27.7K ﹤0.01% 2089
2022
Q4 		$228K Buy
3,700
+1,700
+85% +$90.4K ﹤0.01% 1953
2022
Q3 		$83K Buy
+2,000
New +$87K ﹤0.01% 2481

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's TMDX Position: Q1 2026 in Review

Walleye Capital increased its Transmedics (TMDX) stake by 34% in Q1 2026, buying an estimated $73.2K and bringing the position to 2,213 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #3279.

Walleye Capital first reported a position in TMDX in Q3 2021 and has held it in 11 quarters since. The position peaked at $5.26M in Q3 2023. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Walleye Capital held 2,213 shares of Transmedics worth $220K as of Q1 2026.
  • Walleye Capital bought 561 Transmedics shares in Q1 2026, an estimated $73.2K.
  • Transmedics made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3279 holding.
  • Walleye Capital first reported a position in Transmedics in Q3 2021 and has held it in 11 quarters since.
  • Walleye Capital's Transmedics position peaked at $5.26M in Q3 2023.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.